Full text is available at the source.
Abstract
Plasma GFAP levels were notably higher in cognitively unimpaired older adults with brain amyloidosis (Aβ+) compared to those without (Aβ-).
- GFAP demonstrated the highest effect size and area under the curve (AUC) for distinguishing between Aβ+ and Aβ- individuals.
- While GFAP, p-tau181, and p-tau231 showed similar AUCs, all were significantly higher than that of neurofilament light (NFL).
- The combination of GFAP with a base model including age, sex, and APOE ε4 status achieved an AUC greater than 90%.
- Longitudinally, GFAP and p-tau181 levels increased in Aβ+ individuals, while NFL levels rose in Aβ- individuals over 12 months.
- GFAP, p-tau181, p-tau231, and NFL correlated significantly with cognitive performance, but not with hippocampal volume.
Simplified